All Blogs

Jun 28, 2023

In recent years, ePharmacy has emerged as a key innovation in the healthcare industry, aimed at enhancing medications availability and other healthcare products with greater ease of convenience and cost-effectiveness. Over a short period of time, it has transformed the traditional way of accessing pharmaceutical pr...

Jun 27, 2023

FDA Approves Jardiance for the Treatment of Type 2 Diabetes in Children 10 Years and Older Boehringer Ingelheim and Eli Lilly and Company announced that the FDA has approved Jardiance® (empagliflozin) 10 mg and 25 mg tablets to decrease blood sugar together with diet and exercise in children 10 years and older w...

Aug 13, 2025

Uveitis remains one of the leading causes of preventable vision loss worldwide, accounting for nearly 10–15% of blindness cases in developed countries. Its complex and multifactorial nature poses significant diagnostic and therapeutic challenges, demanding prompt detection and targeted intervention to preserve sigh...

Jun 23, 2023

Allogeneic HSCT is a mainstay for patients with different hematological malignancies, but it requires immunosuppressive strategies before and after HSCT. However, approximately half (50%) of the patients receiving allogeneic hematopoietic stem cell transplantation (HCT) from a human leukocyte antigen (HLA)-matched ...

Jun 22, 2023

Orthofix Launched WaveForm A – 3D Printed Anterior Lumbar Interbody On June 19, 2023, Orthofix Medical Inc., a leading global spine and orthopedics company, launched WaveForm® A, an interbody for Anterior Lumbar Interbody Fusion (ALIF) procedures. For the treatment of patients who require fusion due to degenerat...

Jun 21, 2023

Simulations play a key role in the healthcare industry and are an essential part of medical training. It holds immense potential to improve patient safety by providing safe environments for practice and skill development to healthcare professionals. Furthermore, it enables the detection and mitigation of errors, wh...

Jun 20, 2023

GSK Announces Extension of FDA Review Period for Momelotinib After all, GSK will not hear from the FDA this month about its marketing application for momelotinib as a therapy for anemia in myelofibrosis patients. The pharmaceutical company announced that the US Food and Drug Administration has extended the drug'...

Aug 22, 2025

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by a constellation of symptoms impacting both the autonomic nervous system and motor function. According to the National Organization for Rare Disorders (NORD), MSA affects between 15,000 and 50,000 individuals in the United Sta...

Jun 16, 2023

Dystrophic epidermolysis bullosa (DEB) is an inherited disorder caused by changes in the COL7A1 gene. In this rare condition, blisters form on the skin and the moist inner lining of some organs and body cavities. Depending upon the nature of the inheritance pattern, dystrophic epidermolysis bullosa is divided into ...

Jun 15, 2023

Centinel Spine® Completed Enrollment in First-of-its-Kind 2-Level IDE Trial Evaluating prodisc® C Match-the-Disc™ Cervical TDR System On June 13, 2023, Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease by providing the most robust and clinically-pr...